Sopharma AD-Sofia (WAR:SPH) Retained Earnings : zł940 Mil (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Sopharma AD-Sofia's retained earnings for the quarter that ended in Jun. 2024 was zł940 Mil.

Sopharma AD-Sofia's quarterly retained earnings increased from Dec. 2023 (zł866 Mil) to Mar. 2024 (zł932 Mil) and increased from Mar. 2024 (zł932 Mil) to Jun. 2024 (zł940 Mil).

Sopharma AD-Sofia's annual retained earnings increased from Dec. 2021 (zł973 Mil) to Dec. 2022 (zł1,115 Mil) but then declined from Dec. 2022 (zł1,115 Mil) to Dec. 2023 (zł866 Mil).

Sopharma AD-Sofia Retained Earnings Historical Data

The historical data trend for Sopharma AD-Sofia's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Retained Earnings Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

789.01

789.26

972.73

1,115.45

866.11

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Retained Earnings	Get a 7-Day Free Trial															1,103.35	1,139.41	866.11	932.18	939.96

Sopharma AD-Sofia Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Sopharma AD-Sofia (WAR:SPH) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.